Scientific Director, Medical Payer Strategy - Oncology

About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube.

The Scientific Director, Medical Affairs - Oncology Drives the development and execution of the market access payer, GPO, IDN, guidelines, and clinical pathway scientific strategies within the key Oncology therapeutic areas across all access decision-makers. Works cross-functionally in a highly matrixed environment to support scientific and market access needs of brand and market access commercial, HEOR, and medical affairs. Represents Medical Payer Strategy (MPS), both internally and externally, as the subject matter expert in translating the scientific and HEOR data with cross-functional stakeholders (Commercial, Market Access, HEOR, Clinical Development, etc). Represents V&A Oncology MPS on key cross-functional teams to communicate and integrate medical access evidence needs into the gaps assessment process.

Development and execution of the medical affairs access/HCDM strategy and tactics across all oncology access channels (payer, distribution, IDN, GPO, Clinical Pathways, guidelines) Lead Oncology Clinical Core Team in the development and execution of clinical guidelines and pathways scientific plans. Co-lead Access Brand Team (ABT) with commercial payer strategy to develop US focused brand access strategies, shape evidence generation and pull through tactics Actively participate in relevant cross-functional (e.g., Commercial, Market Access, HEOR, Clinical Development, etc) teams to provide market access scientific and pharmacoeconomic subject matter expertise. Actively participate in global gaps assessment development and provide medical market access input into Integrated Evidence Plans via IEST, presents medical access considerations at VAT and AST Lead the development of strategic resources and provide relevant scientific and technical training. Lead HCDM-focused development of medical pharmacoeconomic materials, medical education programs, advisories, and HCDM symposia. May assist with the scientific review, development, execution, and communication of medical affairs sponsored or supported RWE research activities. Identify and execute strategic initiatives with HCDM-focused professional organizations in oncology focused on enhancing quality of healthcare delivery Create and manage appropriate approval of field materials (slide decks, FAQs, etc.) for use by the Value & Access MOSL team with external access/HCDM customers Partner on the development of HCDM focused Real World Evidence (RWE) with HEOR to support scientific and business strategy which is aligned to Medical Affairs Evidence Gaps; oversees generation of high quality and relevant data; provide training to key stakeholders. Develops strategy for potential access/HCDM collaborative customer research aligned with strategic objectives of the Oncology TA and AbbVie Keeps abreast of scientific, health economic and payer policy through conferences and/or medical literature and acts as a subject matter expert to cross functional stakeholders. Responsible for compliance with applicable Corporate and Divisional Policies and procedures. Responsible for understanding the legal and regulatory requirements as well as, the healthcare landscape and accountable for complying with those requirements. Serves as the scientific team interface for key regulatory, OEC and Legal discussions. Support development of Medical Affairs resources and